Peer Reviewed Cancer Banner
Peer Reveiwed Cancer Cover Image

» Click on Image to View Program Booklet

Vision

To improve quality of life by decreasing the impact of cancer on service members, their families, and the American public

Mission

Fostering the next generation of cancer research by providing new investigators and their early career mentors opportunities to excel in groundbreaking cutting-edge research for the prevention, detection and treatment of cancer

Peer Reviewed Cancer News

Coming Soon! more…

PRCRP Consumers Making a Difference

Coming Soon! More PRC Stories

Research Highlights

Coming Soon! previous highlights…

The Peer Reviewed Cancer Research Program (PRCRP) was established in fiscal year 2009 (FY09) to support research into specifically designated cancers with relevance to military service members and their families. Members of the military are exposed to hazardous environments due to the nature of their service and deployments and, thus, are at risk for the development of different types of cancers. Multiple epidemiological studies have shown an increased incidence in several cancers in military populations, as compared to similar non-military populations. The Veterans Health Administration acknowledged the toll of cancer on military service members and their families in its National Cancer Strategy in 2003 (VHA-Directive 2003-34). In 2007, there were 355,442 military beneficiaries diagnosed with cancer, for a prevalence of 4.1%, comprised of over 60 different cancer types. The cost of cancer-associated care within the Military Health System in FY02 was over $1 billion (Crawford et al Military Medicine 172 (2007) 1084-88). Both a healthy force and healthy family support unit, free of serious illnesses, allows the service member to focus on his or her role as a service member and facilitates the overarching military mission. The PRCRP directly impacts military welfare by providing research into cancers that may develop due to deployments or exposure to various military environments. Funding studies on the detection, diagnosis, treatment, and prevention of these diseases benefits not only the service members and their families, but also the American public, ultimately leading to increased survival rates and decreased costs of medical care.

Congressional Appropriations

Congressional Appropriations

  • $47 million in FY09-11
  • $12.8 million in FY12
Funding Summary

Funding Summary

Peer Review Participants

Peer Review Participants